Showing results (31-40 of 78) with videos related to
Sort By:
Pageof 8
Development (Cambridge, England)|November 23, 2012
Emergence of embryonic pattern through contact inhibition of locomotionJohn R Davis, Chieh-Yin Huang, Jennifer Zanet, et al.International Journal of Systematic and Evolutionary Microbiology|March 7, 2018
Methanolobus psychrotolerans sp. nov., a psychrotolerant methanoarchaeon isolated from a saline meromictic lake in SiberiaSheng-Chung Chen, Hsing-Hua Huang, Mei-Chin Lai, et al.Scientific Reports|July 29, 2020
Clinicomicrobiological profile, visual outcome and mortality of culture-proven endogenous endophthalmitis in TaiwanMing-Chieh Hsieh, San-Ni Chen, Chieh-Yin Cheng, et al.Anticancer Research|April 12, 2015
High expression of phospho-H2AX predicts a poor prognosis in colorectal cancerYi-Chen Lee, Tzu Chieh Yin, Yi-Ting Chen, et al.Frontiers in Oncology|December 3, 2021
Low Ligation Plus High Dissection <i>Versus</i> High Ligation of the Inferior Mesenteric Artery in Sigmoid Colon and Rectal Cancer Surgery: A Meta-AnalysisTzu-Chieh Yin, Yen-Cheng Chen, Wei-Chih Su, et al.Scientific Reports|November 12, 2020
A network-based approach to deciphering a dynamic microbiome's response to a subtle perturbationGrace Tzun-Wen Shaw, An-Chi Liu, Chieh-Yin Weng, et al.Plant Disease|December 18, 2025
Characterization of emerging <i>Pestalotiopsis</i> sensu lato causing foliar blights on conifers in Taiwan and a preliminary assessment of fungicide susceptibilityYuan-Cheng Xu, Wen-Wei Hsiao, Cheng-Yi Yang, et al.Journal of Pain and Symptom Management|January 27, 2019
The Effect of 20-Minute Mindful Breathing on the Rapid Reduction of Dyspnea at Rest in Patients With Lung Diseases: A Randomized Controlled TrialSeng-Beng Tan, Chong-Kin Liam, Yong-Kek Pang, et al.Plos One|July 19, 2012
Mirtazapine inhibits tumor growth via immune response and serotonergic systemChun-Kai Fang, Hong-Wen Chen, I-Tsang Chiang, et al.Oncology Research|February 18, 2022
Comparison of <i>UGT1A1</i> Polymorphism as Guidance of Irinotecan Dose Escalation in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as the First-Line TherapyHsiang-Lin Tsai, Yen-Cheng Chen, Tzu-Chieh Yin, et al.Pageof 8